|
|
Title | Creator | Relation Is Part Of |
1 |
|
Involvement in Multiple Sclerosis | Norman J. Schatz | NANOS 1982: Various Subjects Symposium (Session 2) |
2 |
|
The Association Between Multiple Sclerosis and Uveitis (.pdf) | Tine Gadegaard Olsen; Jette Frederiksen | NANOS Annual Meeting 2016: Poster Presentations |
3 |
|
Contemporary Imaging of Multiple Sclerosis Using Triple-dose and 3.0 T: Preliminary Safety Data from the "BECOME" Study | Roger E. Turbin; Nilay S. Sethi; Diego N. Cadavid; Leo J. Wolansky; Jiang Liu; George Joseph; Mohammad H. Haghighi; Joan H. Skurnick; Larry P. Frohman; Stuart D. Cook | |
4 |
|
Immunology of Multiple Sclerosis | Barry G. W. Amason | NANOS 1996: Multiple Sclerosis Symposium |
5 |
|
Should We Ever Consider Stopping Disease-Modifying Treatment for MS? | Robert Shin | NANOS 2011: Multiple Sclerosis & Neuromyelitis Optica: The State of the Art |
6 |
|
The predictive value of brain MRI in acute optic neuritis for developing multiple sclerosis | Jette L. Frederiksen; Nadia N. Poulsen | NANOS 2014: Poster Presentations |
7 |
|
Emerging Therapies of Multiple Sclerosis | Jeffrey Bennett, MD, PhD | NANOS 2011: Multiple Sclerosis & Neuromyelitis Optica: The State of the Art |
8 |
|
Pediatric Optic Neuritis and Risk of Multiple Sclerosis | Grant T. Liu | NANOS 2011: Multiple Sclerosis & Neuromyelitis Optica: The State of the Art |
9 |
|
Comparison of Visual Function Tests in an MS Cohort | Laura J. Balcer, MD, MSCE; Ligia Nano-Schiavi, CO; Dina A. Jacobs, MD; Clyde E. Markowitz, MD; Dorothea C. Pfohl, RN; Steven L. Galetta, MD; Maureen G. Maguire, PhD | NANOS 2003: Scientific Platforms Presentations I |
10 |
|
Immunomodulatory Therapies and Low Dose Azathioprine Reverse Partially and Significantly Visual and Neurologic Deficits in Progressive Forms of Multiple Sclerosis | Dan Milder, MD | |
11 |
|
Multiple Sclerosis - Diagnosis and Prognosis | Wayne T. Cornblath, MD | NANOS 1996: Multiple Sclerosis Symposium |
12 |
|
Visual Dysfunction in MS Is Associated with Abnormalities in Normal-Appearing Gray and White Matter | Laura J. Balcer; Gregory F. Wu; Jayaram K. Udupa; Tianhu Lei; Tad Iwanaga; Eric D. Schwartz; Lisa M. Desiderio; M. Ligia Nano-Schiavi; Steven L. Galetta; Maureen G. Maguire; Gary R. Cutter | |
13 |
|
Visual Function and Disease Phenotype in Multiple Sclerosis | Gregory F. Wu, MD, PhD; M. Ligia Nano-Schiavi, CO; Steven L. Galetta, MD; Jeffrey A. Cohen, MD; Laura J. Balcer, MD, MSCE | NANOS 2004: Scientific Platform Presentations (Session 2) |
14 |
|
Existing Therapies for Treatment of MS | Ari J. Green, MD | NANOS 2011: Multiple Sclerosis & Neuromyelitis Optica: The State of the Art |
15 |
|
Extra-Axonal Ocular Damage Quantification by Multifocal Electroretinography in Chronic Progressive Multiple Sclerosis | Arielle R. Spitze; Nagham Al-Zubidi; Sushma Yalamanchili; Fiona Costello; Andrew G. Lee | NANOS 2013: Poster Presentations |
16 |
|
Starting and Switching Multiple Sclerosis Therapy | Steven L. Galetta, MD | NANOS 2011: Multiple Sclerosis & Neuromyelitis Optica: The State of the Art |
17 |
|
The Optic Nerve: "Tip of the Iceberg" of Demyelination | Mark J. Morrow | NANOS 2011: Multiple Sclerosis & Neuromyelitis Optica: The State of the Art |
18 |
|
Neuromyelitis Optica Spectrum Disorders: Diagnosis and Treatment | Dean M. Wingerchuk, MD, MSc, FRCP(C) | NANOS 2011: Multiple Sclerosis & Neuromyelitis Optica: The State of the Art |
19 |
|
Analysis of the Ten-Year Evaluation of the ONTT Patients | Mark J. Kupersmith | NANOS 2004: Scientific Platform Presentations (Session 2) |
20 |
|
Comparison of Multifocal Objective Pupil Perimetry and MRI in Multiple Sclerosis | Christian J. Lueck; Eman Ali; Cristian Voicu; Andrew James; Andrew Janke; Teddy Maddess | NANOS 2012: Scientific Platform Presentations (Session II) |
21 |
|
Immunoglobin Heavy-Chain Repertoire Bias and the Risk of Demyelinating Disease in Isolated Optic Neuritis | J. Bennett; A. Ritchie; K. Haubold; D. Gilden; G. Owens | NANOS 2006: Scientific Platform Presentations (Session I) |
22 |
|
Management of Acute Optic Neuritis : Survey of Ophthalmologists and Neurologists in the South-East United States | Busaba Sathornsumetee; Carolyn D. Drews-Botsch; Seegar Swanson; Nancy J. Newman; Valerie Biousse | NANOS 2006: Poster Presentations |
23 |
|
Ophthalmic evaluations in clinical studies of fingolimod (FTY720) in multiple sclerosis (MS) | Marco Zarbin; Anthony T. Reder; William Collins; Gordon Francis; Xiaoli Zhang; Ludwig Kappos; Jeffrey A. Cohen | NANOS 2012: Poster Presentations |
24 |
|
Opsoclonus and Ocular Flutter in Multiple Sclerosis | Christian Wertenbaker, MD; Marc Ellman, MD | NANOS 2003: Poster Presentations |
25 |
|
Advances in MS Therapy | Bart K. Chwalisz, MD | NANOS Annual Meeting 2022: State of the Art in Neuro-Ophthalmic Disease |